| ²é¿´: 1693 | »Ø¸´: 4 | ||
ZC6818418гæ (³õÈëÎÄ̳)
|
[ÇóÖú]
Journal of Chromatographic Science Éó¸åµÄÓйØÎÊÌâ ÒÑÓÐ1È˲ÎÓë
|
|
ÓÐÁ½¸öÎÊÌ⣺ 1£¬¸ÃÔÓÖ¾µÄ²Î¿¼ÎÄÏ×ʲôҪÇó°¡£¬¸ÄÁËÁ½»ØÁË£¬¶¼²»¶Ô£¬Âé·³´ó¼Ò¿´ÏÂÄÄÀï²»·ûºÏÒªÇó¡£ Reference list Accession numbers may be cited either within the text or in the form of a reference. The normal form of listed references is author's surname, initials; article title; journal name in full, year in parenthesis; volume number and inclusive page numbers. Include titles with all journal articles. In addition, if you are citing a work listed as "In Press", please provide a copy of that work with your submitted manuscript. Examples£º Journal article (already published in an issue):Vanatta, L.E., Slingsby, R.W.; United States Environmental perchlorate Method 332.0 via microbore and capillary chromatographic formats; Journal of Chromatographic Science, (2009); 47: 1-7.2£¬ ÎÒдµÄ²Î¿¼ÎÄÏ×£º 1. kalkman, H.O.,FUUERBACH,D.,Lotscher,E.,Schoeffter,P.,life science,(2003);1151 .U.S. FDA, Guidance for Industry: Bioanalytical Method Validation, CDER, Rockville, MD, 2001. 2. Caccia, S., Luca, P. and Nobili A.; New Atypical Antipsychotics for Schizophrenia: Iloperidone. Drug Design, Development and Therapy,(2010); 4:33-48. 3. Fairweather, D.B., Young, F. and Zaninelli, R.; Iloperidone is Effective and well Tolerated in the long Term Treatment of Schizophrenia and Schizoaffective Disorder. European Neuropsychopharmacology, (2002); 12(Supplement 3):277-278. 4. Kalkman, H.O., Feuerbach, D. Lötscher, E. and Schoeffter, P.; Functional Characterization of the Novel AntipsychoticIloperidone at Human D2,D3,a2c,5-HT6,and 5-HT1A Receptors; Life Science, (2003); 73(03):1151-1159. 5. Ichikawa, J., Li, Z., Dai, J. and Meltzer, H.Y., Atypical antipsychotic drugs, quetiapine, Iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism; Brain Res, (2002); 956: 349. 6. Kalkman, H.O., Subramanian, N. and Hoyer, D.; Extended Radioligand Binding Profile of Iloperidone: A Broad Spectrum Dopamine/Serotonin/Norepinephrine Receptor Antagonist for the Management of Psychotic Disorders; Neuropsychopharmacology, (2001); 25: 904. 7. Kalkman, H.O., Feuerbach, D., Lötscherscher, E. and Schoeffter, P.; Functional characterization of the novel antipsychotic Iloperidone at human D2, D3, ¦Á2C, 5-HT6, and 5-HT1A receptors; Life Sci, (2003); 73: 1151. 8. Kongsamut, S., Roehr, J.E., Cai, J., Hartman, H.B., Weissensee, P., Kerman, L.L., Tang, L. and Sandrasagra, A.; Iloperidone binding to human and rat dopamine and 5-HT receptors; Eur. J. Pharmacol, (1996); 317: 417. 9. Christoph, U., Todd, L. and Anil, K.; Antipsychotic Drugs and Obesity; Trends in Molecular Medicine, (2011); 17(2): 271-107. 10. Kalkman, H.O., Matkovits-Gupta, T., Alphs, L. and Gharabawi, G.; Iloperidone: A novel dopamine/serotonin antagonist with a unique preclinical profile; Eur. Neuropsychopharmacol, (1999); 9: 282. 11. Citrome, L. Meng, X.Y and Hochfeld, M.; Efficacy of Iloperidone in schizophrenia: A PANSS five-factor analysis; Schizophr. Res, (2011); 131: 75-81. 12. Crabtree, B.L. and Montgomery, J.; Iloperidone for the Management of Adults with Schizophrenia; Clin.Ther, (2011); 33: 330. 13. Sainati, S.M., Hubbard, J.W., Chi, E., Grasing, K. and Brecher, M.B.; Safety, tolerability, and effect of food on the pharmacokinetics of Iloperidone (HP 873), a potential atypical antipsychotic; J. Clin. Pharmacol, (1995); 35: 713-718. 14. Mutlib, A.E. and Strupczewski, T.; Picogram Determination of Iloperidone in Human Plasmaby solid-phase Extraction and by High-performance Liquid Chromatography-selected-ion Monitoring Electrospray Mass Spectrometry; Journal of Chromatography, (1995); 669:236-246. 15. Jia, M., Li, ., He, X.M, Liu M.Z., Zhou Y., Fan,Y., Li,W.Y., Simultaneous determination of Iloperidone and its two activemetabolites in human plasma by liquid chromatography¨Ctandem mass spectrometry: Application to a pharmacokinetic study; Journal of Chromatography B, 928 (2013) 52¨C 57. 16. Thompson, A., Chrisian, L. and Volpi, S.; Absence of Weight Gain Association with the HTR2C-759C/T Polymorphism in Patients with Schizophrenia Treated with Iloperidone; Psychiatry Research, (2010); 175:271-273. 17. Alasdair, M.B., Susan, B., Athina, M. and Mark, A.G.; Iloperidone Reduces Sensorimotor Gating Decits in Pharmacology models, but not a Developmental Model, of Disrupted Preulse Inhibition in Rats; Neuropharmacology, (2006); 51(04):457-465. 18. GEMPERLE, A.Y., ENZ, A. and POZZA, M.F.; Effects of Clozapine, Haloperidoland Iloperidone on Neurotransmission and Synaptic Prefrontal Cortex and their Accumulation in Brain Tissue: an in Vitor Study; Neuroscience, (2003); 117:681-695. 19. Citrome, L.; Iloperidone for Schizophrenia: A Review of the Efficacy and Safety Profile for this newly Commercialized Second-generation Antipsychotic; Int J Clin Pract, (2009); 63(8):1237-1248. 2£¬±¾ÎÄÐèÒªÖØ´óÐ޸ģ¬»Ø¸´Ê±µÄ¸ñʽÓÐʲôעÒâµÄô£¬ÒÔ¼°ÊÇ·ñÐèÒª¸ù¾ÝÉó¸åÒâ¼ûÒ»Ò»¶ÔÓ¦¸ø³ö´ð¸´ÄØ£¿ |
» ²ÂÄãϲ»¶
0855Çóµ÷¼Á²ÄÁÏ
ÒѾÓÐ12È˻ظ´
297·Ö083200ÇóÖú
ÒѾÓÐ7È˻ظ´
070300»¯Ñ§Ñ§Ë¶311·ÖÇóµ÷¼Á
ÒѾÓÐ10È˻ظ´
ר˶0854³õÊÔ¿¼²Ä¿Æ»ù£¬Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
0857´óÀà»·¾³¹¤³ÌBÇøÇóµ÷¼Á
ÒѾÓÐ3È˻ظ´
0817»¯Ñ§¹¤³ÌÓë¼¼ÊõÇóµ÷¼Á£¬Ò»Ö¾Ô¸Öк£Ñó319
ÒѾÓÐ14È˻ظ´
0703»¯Ñ§µ÷¼Á325·Ö
ÒѾÓÐ11È˻ظ´
286Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£©
ÒѾÓÐ4È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ceramics international Ͷ¸å ±ØÐëÍÆ¼öÉó¸åÈËÂð
ÒѾÓÐ7È˻ظ´
Scientific Journal of Computer Science Õâ¸öÆÚ¿¯ÔõôÑù£¿
ÒѾÓÐ14È˻ظ´
Ͷ¹ýJournal of Nanofluids Õâ¸öÆÚ¿¯µÄÇë½ø£¬»òÕßÁ˽âµÄÒ²ÐУ¬ÒªÊÇÉó¸åÈ˾͸üºÃÁË
ÒѾÓÐ6È˻ظ´
Journal of membrane scienceͶ¸å±»¾ÜºóÇóÖú¡«
ÒѾÓÐ19È˻ظ´
European Journal of Medicinal Chemistry Éó¸åÈ˵ÄÒâ¼ûÓÐÒ»Ìõ²»ÊǺÜÃ÷°×£¬ÇóÖú´ó¼Ò£¡
ÒѾÓÐ3È˻ظ´
Journal of Reinforced Plastics and Composites Ͷ¸åÇóÖú
ÒѾÓÐ10È˻ظ´
petroleum science and technology µÄÉó¸åÈËÒâ¼û
ÒѾÓÐ6È˻ظ´
¹ØÓÚ¡¶ASIAN JOURNAL OF CHEMISTRY¡·
ÒѾÓÐ4È˻ظ´
scienceµÄ¾Ü¸å״̬ÊÇʲô£¿
ÒѾÓÐ5È˻ظ´
ÄÄλ֪µÀIranian Journal of Pharmaceutical ResearchÉó¸åÖÜÆÚºÍ¼û¿¯µÄËÙ¶È£¿
ÒѾÓÐ10È˻ظ´
Journal of Materials Science Ͷ¸å Éó¸åÈËÈçºÎÑ¡Ôñ£¿
ÒѾÓÐ8È˻ظ´
ÇóÖú Journal of Chromatographic ScienceÉó¸åÈËÒâ¼û»Ø´ð
ÒѾÓÐ4È˻ظ´
ÇóÒÁÀÊJournal of Agricultural Science and Technology (JAST)ÔÓÖ¾µÄͶ¸å¾Ñé
ÒѾÓÐ9È˻ظ´
ÓÐͶfrontiers of computer scienceÆÚ¿¯µÄÂð
ÒѾÓÐ13È˻ظ´
LC GC NORTH AMERICA Ͷ¸åÇóÖú
ÒѾÓÐ11È˻ظ´
journal of BiosciencesͶ¸å¾Ñé
ÒѾÓÐ8È˻ظ´
Science of Advanced MaterialsÆÚ¿¯ Ͷ¸åÇóÖú
ÒѾÓÐ9È˻ظ´
¡¶Journal of Materials Science¡·µÄ×÷ÕßÍÆ¼öÉó¸åÈË£¿
ÒѾÓÐ5È˻ظ´
ÇóÖú£º¹ØÓÚ¡¶Journal of chromatographic science¡·Í¶¸åÒªÇó·½ÃæµÄÎÊÌâ
ÒѾÓÐ5È˻ظ´
ÓÐͶ¹ý¡¶¸ß·Ö×Óͨ±¨¡·µÄû
ÒѾÓÐ5È˻ظ´
ÇóÖúJournal of pest scienceµÄͶ¸åÄ£°æ
ÒѾÓÐ3È˻ظ´
×Ô˽µÄè1988
ÈÙÓþ°æÖ÷ (ÎÄ̳¾«Ó¢)
- Ó¦Öú: 4800 (¸±½ÌÊÚ)
- ¹ó±ö: 6.746
- ½ð±Ò: 50040.4
- É¢½ð: 11517
- ºì»¨: 256
- ɳ·¢: 134
- Ìû×Ó: 11684
- ÔÚÏß: 1473.7Сʱ
- ³æºÅ: 2004083
- ×¢²á: 2012-09-16
- ÐÔ±ð: GG
- רҵ: Óлú·Ö×Ó¹¦ÄܲÄÁÏ»¯Ñ§
- ¹ÜϽ: ÂÛÎÄͶ¸å
2Â¥2014-12-06 16:12:06
ZC6818418
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 70.5
- Ìû×Ó: 9
- ÔÚÏß: 3.7Сʱ
- ³æºÅ: 2475071
- ×¢²á: 2013-05-21
- רҵ: É«Æ×·ÖÎö
3Â¥2014-12-07 18:56:17
ZC6818418
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 70.5
- Ìû×Ó: 9
- ÔÚÏß: 3.7Сʱ
- ³æºÅ: 2475071
- ×¢²á: 2013-05-21
- רҵ: É«Æ×·ÖÎö
4Â¥2014-12-07 18:56:29
¶ûÐ쳤Çä
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 917.8
- É¢½ð: 771
- Ìû×Ó: 145
- ÔÚÏß: 100.4Сʱ
- ³æºÅ: 1628366
- ×¢²á: 2012-02-20
- רҵ: ÖÐҩѧÆäËû¿ÆÑ§ÎÊÌâ
5Â¥2015-11-19 10:56:59














»Ø¸´´ËÂ¥

